Sentence examples for medicinal regulation from inspiring English sources

E-cigarette companies, supported by growing legions of e-cigarette users, had lobbied hard against medicinal regulation.

Shortly after noon the next day, Ms. Ries's amendment deleting the demand for medicinal regulation passed easily.

In early October, Frédérique Ries, a Belgian member of the European Parliament and a political ally of Mr. Davies, drafted an amendment to scrap a clause requiring medicinal regulation for e-cigarettes.

In the European Union, for exemple, the legislation for orphan medicinal products (Regulation EC No 141/2000) and for paediatrics (Regulation EC No 1901/2006) have succesfully included key elements to protect the interests of these patient groups.

However, major obstacles for the clinical application of bacteriophages are the perception of viruses as 'enemies of life' [13], the lack of a specific frame for phage therapy in the current Medicinal Product Regulation [14] and the absence of well-defined and safe bacteriophage preparations.

The processing and fractionation of plasma operates to industry standards and must comply with medicinal product regulation in order to minimise the risks of infection or viral transmission or contamination [ 15].

More in particular, a specific European framework covering advanced therapy medicinal product (Regulation 1394/2007) was created, offering legal incentives (e.g., scientific advice at reduced costs) to developers of cell and gene based therapies.

An important theme arising from the interactions in the European Policy Workshop related to the role and limitations of current European GMO safety legislation and medicinal product regulations as they pertain to future health related developments in the field of SynBio.

It was the first company to take advantage of Australia's new medicinal cannabis regulations, which came into force last year and allows anyone to apply for a licence to research and grow medicinal cannabis, as well as manufacture cannabis pharmaceuticals.

In the framework of the authorisation of medicinal products regulated by the Regulation (EC) No 726/2004 and Directive 2001/83/EC as amended and the CTD, and additional implementing Directives and guidelines, the new Regulation (EC) No 1901/2006 is an important new piece of legislation focusing on the requirements to improve the situation for the paediatric population.

Under the EU orphan drug Regulation, medicinal products designated as OMPs gain ten-years of market exclusivity on the granting of a marketing authorisation in the orphan indication.